Barclay Healthcare & Biotechnology Index
This directional strategy involves equity-oriented investing on both the long and short sides of the market. The objective is not to be market neutral. Managers have the ability to shift from value to growth, from small to medium to large capitalization stocks, and from a net long position to a net short position. Managers may use futures and options to hedge. The focus is sector specific and concentrates on the Healthcare & Biotechnology sectors. The index is simply the arithmetic average of the net returns of all funds within the category that have reported that month.
The Barclay Healthcare & Biotechnology Index is recalculated and updated real-time on this page as soon as the monthly returns for the underlying funds are recorded. Only funds that provide us with net returns are included in the index calculation. The number of funds that are currently included in the calculations for the most recent months can be found in the footnotes below. Please note that the calculation for the number of funds is time-stamped and that the number of funds will continue to increase until all funds categorized within the sector have reported monthly returns.
|†Estimated performance for February 2017 calculated with reported data from 45 funds.|
|§Estimated performance for January 2017 calculated with reported data from 53 funds.|
|*All estimates and 2017 YTD amounts are calculated with reported data as of March-23-2017 03:16 US CST.|
Past performance is not necessarily indicative of future trading results. The funds represent speculative investments and involve a high degree of risk. An investor could lose all or a substantial portion of his or her investment.